CX Institutional Invests $438,000 in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

CX Institutional acquired a new stake in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 10,183 shares of the company’s stock, valued at approximately $438,000. CX Institutional owned about 0.21% of SPDR S&P Pharmaceuticals ETF at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in XPH. BNP Paribas Financial Markets raised its position in SPDR S&P Pharmaceuticals ETF by 208.6% in the third quarter. BNP Paribas Financial Markets now owns 149,419 shares of the company’s stock worth $6,628,000 after purchasing an additional 101,000 shares in the last quarter. Rockport Wealth LLC acquired a new position in shares of SPDR S&P Pharmaceuticals ETF in the 2nd quarter valued at $1,813,000. Stifel Financial Corp bought a new stake in SPDR S&P Pharmaceuticals ETF during the 3rd quarter worth approximately $337,000. First Citizens Bank & Trust Co. raised its stake in shares of SPDR S&P Pharmaceuticals ETF by 9.5% in the 3rd quarter. First Citizens Bank & Trust Co. now owns 72,053 shares of the company’s stock valued at $3,196,000 after purchasing an additional 6,227 shares during the period. Finally, JPMorgan Chase & Co. lifted its stake in SPDR S&P Pharmaceuticals ETF by 36.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 4,443 shares of the company’s stock valued at $197,000 after acquiring an additional 1,182 shares in the last quarter.

SPDR S&P Pharmaceuticals ETF Stock Performance

NYSEARCA:XPH opened at $45.00 on Friday. The company has a market cap of $218.25 million, a P/E ratio of 14.39 and a beta of 0.87. The stock’s 50-day simple moving average is $44.39 and its 200 day simple moving average is $44.24. SPDR S&P Pharmaceuticals ETF has a 52-week low of $38.88 and a 52-week high of $48.76.

About SPDR S&P Pharmaceuticals ETF

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.